Drug-drug interaction studies between hepatitis C virus antivirals sofosbuvir/velpatasvir and boosted and unboosted human immunodeficiency virus antiretroviral regimens in healthy volunteers | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Drug-drug interaction studies between hepatitis C virus antivirals sofosbuvir/velpatasvir and boosted and unboosted human immunodeficiency virus antiretroviral regimens in healthy volunteers

Mogalian E, Stamm LM, Osinusi A, et al. Drug-drug interaction studies between hepatitis C virus antivirals sofosbuvir/velpatasvir and boosted and unboosted human immunodeficiency virus antiretroviral regimens in healthy volunteers. Clin Infect Dis. 2018;56(6):934-940.

Publication Type:

Journal Article

Authors:

Mogalian, E; Stamm, LM; Osinusi, A; et, al

Source:

Clin Infect Dis, Volume 56, Issue 6, p.934-940 (2018)

Cited On:

Patients With HIV/HCV Coinfection

Export Citation:

RIS Format

Top